U.S. District Judge Matthew Kennelly of the Northern District of Illinois has issued a schedule of bellwether trials for six Androgel lawsuits. The trials are expected to begin in April and conclude in November of 2017. The issuance of this schedule rejected a request by the defendants to bifurcate... Read more »

The first bellwether trials in multidistrict litigation 2545, which concerns injuries allegedly caused by testosterone replacement therapy, are slated to go to trial by fall of 2016. Court dockets show that more than 2,700 complaints are currently pending against the manufacturers of Testim, Adroderm, Androgel, Axiron and other products that... Read more »

A plaintiff who filed a lawsuit against multiple manufacturers of testosterone therapy products claims use of Testim and Androgel led to his heart attack in 2013. The plaintiff has joined more than 3,000 other plaintiffs with similar allegations. Those lawsuits have been coordinated into multidistrict litigation in Illinois District Court. The plaintiff... Read more »

On September 30, 2015, a husband and wife filed their complaint in the ongoing Testosterone Replacement Therapy Products multidistrict Litigation (MDL) against drug makers including AbbVie, Eli Lilly, Pfizer, and several others. These cases, which have been consolidated before Judge Matthew F. Kennelly of the U.S. District Court for the... Read more »

In July, researchers from the University of North Carolina at Chapel Hill published a study on testosterone heart risks in the medical journal, JAMA Internal Medicine, finding that the side effects of testosterone injections may pose the highest risk of cardiovascular events, hospitalizations and deaths. The team examined the comparative... Read more »

In the August 20, 2015 issue of the New England Journal of Medicine, FDA researchers published an article that expressed their concerns regarding testosterone therapy side effects. Specifically, they are concerned about the use of these products by men who have declining testosterone caused by the natural aging process, rather... Read more »

The use of testosterone replacement therapy (TRT) has been increasing, yet some have expressed concerns about potentially life-threatening side effects of testosterone gels, creams, patches, and other products. Cardiovascular complications are of particular concern. Some men have filed lawsuits against a handful of TRT product manufacturers, claiming that the drugs... Read more »

On August 13, 2015, two New York residents filed an AndroGel lawsuit, alleging that the drug caused a stroke on multiple occasions. The plaintiffs, Denis Sitruk and Suzanne Sitruk, have added their complaint to the multidistrict litigation (MDL) No. 2545, which is proceeding in the U.S. District Court for the... Read more »

The number of product liability complaints regarding testosterone replacement therapy continues to skyrocket, with allegations that the products caused heart attacks, stroke, and debilitating blood clot injuries. Men who took supplements such as Axiron, Testim and Androgel are seeking fair compensation and justice through the legal system, based on counts... Read more »

On July 1, 2015, a West Virginia-based plaintiff filed a personal injury and product liability lawsuit alleging that the drugs AndroGel and Axiron caused the onset of a pulmonary embolism – and the defendants failed to properly warn him of this known risk. The lawsuit was filed within the established multidistrict... Read more »